In order to properly interpret the results of a diagnostic gene panel sequencing test, gene coverage needs to be taken into consideration. If coverage is too low, an additional re-sequencing test is needed to make sure that a pathogenic variant is not missed. To facilitate the interpretation of coverage data, we designed CovReport, a novel easy-to-use visualization tool. CovReport generates a concise coverage summary that allows one-glance assessment of the sequencing test performance. Both genelevel and exon-level coverage can be immediately appreciated and taken into consideration for further medical decisions. CovReport does not require complex installation and can thus be easily implemented in any diagnostic laboratory setting. A user-friendly interface generates a graphic summary of coverage that can be directly included in the diagnostic report. In addition to a stand-alone version, we also provide a command line version of CovReport that can be integrated into any bioinformatics pipeline. This flexible tool is now part of routine sequencing analysis at the Department of Medical Genetics at La Timone Hospital (Marseille, France).
Background
Since arrival of short-read sequencing technologies, significant efforts have been spent to improve the quality of the obtained data in order to satisfy the requirements of molecular diagnostics. However, many regions of human genome remain difficult to analyze using standard short-read sequencing approaches. These "dark" genome regions contain a number of genes responsible for human diseases [1] . For example, several neuromuscular disease-causing genes, such as NEBULIN (NEB) and SELENON (SEPN1), overlap these difficult to sequence regions. Disease-causing variants in gene regions with suboptimal sequence coverage can be overlooked. Thus, when short-read sequencing is performed in a diagnostic setting, identifying poorly-covered regions is critical for the interpretation of a diagnostic sequencing result. If coverage is not sufficient even for a small region of a highly suspected candidate gene, an additional re-sequencing test is needed to make sure that the pathogenic variant is not missed. To facilitate the coverage data interpretation by test prescribers, we designed a novel easy-touse visualization tool, CovReport. The concise coverage data summary generated by CovReport allows one-glance assessment of the sequencing test performance.
Methods

Implementation
CovReport is implemented as a standalone Java application. It can run on any platform where Java The application user interface is in English, but the generated PDF file is in the current locale language.
English and French are supported in the current distribution, but other languages can be added by the user. The text included in the output pdf report can also be customized, making it possible to adopt CovReport in any diagnostic setting. 
Results
CovReport allows one-glance overview of exon coverage for a diagnostic sequencing test by generating a concise easy-to-understand report in the PDF format. Intuitive interface and absence of complex installation steps makes CovReport easy to apply by users without special bioinformatics training.
CovReport can also be launched by command line allowing integration into any bioinformatics pipeline.
Several features make CovReport especially useful in a diagnostic setting. First, the application runs on a local computer allowing complete data security. Second, the patient's name from the previous analysis is automatically reset upon entering the new coverage file in order to avoid identity errors.
Third, the format, content and the language of the report can be easily customized by the laboratory, adapting to any diagnostic setting. Fourth, information about additional Sanger re-sequencing of suboptimally covered regions can be integrated into the coverage report of the initial short-read sequencing allowing easy tracing of sequencing experiments. To demonstrate the performance of CovReport, we used exome sequencing data for NA12878 to visualize the coverage of 40 genes on the extended Limb-Girdle Muscular Dystrophy (LGMD) gene list defined by the French National Network for Rare Neuromuscular Diseases [4] . Coverage module of
VarAFT [2] was used to obtain exon coverage for these genes. The default options were used to generate the pdf report using CovReport with Show gene transcript and Show statistics options activated. As seen from Figure 1 , coverage was visualized for 43 transcripts corresponding to 40 genes.
Most of the genes were covered at 100%. The advantage of using Show gene transcript option is clear from this example, since TTN (NM_133379) is covered at 100%, while TTN (NM_001267550) has several exons with lower coverage. Indeed, NM_133379 isoform is much shorter, as exons 50-219 of NM_001267550 are not included in this transcript. Six exons had no regions with above 20x threshold coverage (black exons). Several other exons had suboptimal coverage in regions corresponding to more than 10% of their length (dark gray). If similar coverage of these genes is obtained after a diagnostic sequencing for a patient affected with LGMD, the prescribing clinician will take into account the presentation of the disease in order to decide if the phenotype of the patient could be potentially explained by pathogenic variants in the exons with low coverage. If that is the case, additional resequencing of these regions will be necessary.
Figure1
. Example of a coverage report provided by CovReport.
Discussion
Importance of coverage data is well established in genetic diagnostics. Indeed, most sequencing reports provide some information about coverage of target regions. However, these data are usually presented as an overall gene panel coverage or as an average-per-gene coverage. To our knowledge, no exon-level coverage data are provided with diagnostic reports. However, the distribution of pathogenic variants in a given gene is not homogeneous, as the disease-causing amino acid changes are often clustered in functionally important regions of the protein. Thus, information about coverage of the regions where disease-causing variants are concentrated is much more informative than an overall average gene coverage [5] . CovReport highlights individual exons with suboptimal coverage, facilitating the interpretation of the sequencing data.
The ultimate goal of diagnostic sequencing is to obtain an above-threshold coverage for the entire genomic area targeted by a given gene panel. This is feasible for small panels with genes that can be robustly sequenced. However, this goal is much harder to achieve for larger gene panels containing difficult to sequence genes. This is the case for the neuromuscular disorder field, since 33 out of 203 genes on the consensus myopathy gene lists [4] contain "dark" regions of the genome that are not easily accessible using standard short-read sequencing approaches [1] . Disease-causing variants in these regions can therefore be overlooked leading to a false negative molecular diagnostic result.
CovReport effectively highlights and draws attention to the exons with suboptimal coverage, allowing the prescriber to evaluate the need for a complementary re-sequencing test for these areas.
Given the critical importance of coverage data, several tools have been previously developed to evaluate the coverage of target regions after short-read sequencing in a diagnostic setting [2, 6, 7] .
While these tools are useful to monitor quality control of runs and samples during technical validation of sequencing tests, unlike CovReport, they do not provide exon-level coverage visualization that can be directly annexed to the diagnostic report.
In conclusion, CovReport generates a one-glance graphical overview of coverage for individual exons on a gene panel, facilitating interpretation of the sequencing test. CovReport is flexible and easy-touse, making it easy adopt in any diagnostic setting.
